NCT07746531ClinicalTrials.gov
Robotic Minimally Invasive Benign Hysterectomy Post-Market Clinical Study With the DEXTER Robotic System
En bref
The purpose of this post-market, observational study is to collect real-world data under anticipated conditions of use that demonstrates that the device performs as intended (accurate, precise control of surgical instruments) in patients undergoing robotic-assisted and laparoscopic hysterectomy for benign…
Observationnelle112 participants recherchés2 sites1 pays
Enregistré dans 1 registre
- ClinicalTrials.govNCT07746531Ouvrir cette fiche sur ClinicalTrials.govSynchronisé avant-hier
Une même étude peut être enregistrée dans plusieurs registres. Nous l'affichons une seule fois et renvoyons vers chaque fiche que nous détenons.
Les informations de l'essai sont affichées telles que publiées par le registre, dans leur langue d'origine.
Cette étude vous intéresse ?
Se connecter ou créez un compte pour manifester votre intérêt et suivre cette étude.
How this study is set up
The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.
- Present: Registered before enrolment beganFirst posted 2026-08-05; recorded start 2026-08-20
- Present: Has a defined primary outcomeA primary outcome measure is listed in the record
- Present: The primary outcome states a time frameThe primary outcome measure records a time frame
- Not stated: Whether participants are randomly assigned is not stated in the registry recordNo allocation method is recorded
- Not stated: Whether there is a comparison group is not stated in the registry recordThe record does not describe the study arms
- Not stated: Whether the study is blinded is not stated in the registry recordNo masking information is recorded
- Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
- Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
- Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
- Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
- Present: Sponsor has 5 other studies in this databaseCounted from the lead sponsor named in the record (Distalmotion SA)
- Not stated: No posted results from this sponsor are in this database yetBased on the sponsor’s studies in this database
- The record lists 1 condition.
- Lead sponsor type recorded as: industry.
Trial stature
Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.
An exploratory-stage design for a study of this type, judged from its ClinicalTrials.gov record.
How this score is built
- Randomised allocation0/20
Allocation not stated in the record
- Blinding0/20
Masking not stated in the record
- Control arm0/15
No comparator arm stated in the record
- Primary-outcome specificity10/10
Named primary outcome with a defined time frame
- Endpoint type3/10
Surrogate or intermediate endpoint (conservative default)
- Multi-centre5/8
Multi-centre: 2 sites
- Data monitoring committee0/7
No data monitoring committee stated
- Prospective registration5/5
Registered before the study start date
- Protocol / SAP posted0/5
No protocol or SAP posted to the registry
A small study: 112 participants (target), run at 2 sites.
How this score is built
- Enrolment19/40
112 participants (target)
- Site count4/25
2 sites
- Country count0/15
Single country
- Planned duration7/10
Planned over about 28 months
- Sponsor scale2/10
Distalmotion SA has led 6 trials in our corpus
We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.
How this score is built
- Investigator standing0/100
No investigator recorded in the registry for this trial
These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.
Résumé
The purpose of this post-market, observational study is to collect real-world data under anticipated conditions of use that demonstrates that the device performs as intended (accurate, precise control of surgical instruments) in patients undergoing robotic-assisted and laparoscopic hysterectomy for benign disease.
Affections
- Hysterectomy, Benign Uterine Diseases
Éligibilité
| Sexe | Femme |
|---|---|
| Âges | 22 Years – Aucun maximum |
| Volontaires sains | Non |
| Méthode d'échantillonnage | NON_PROBABILITY_SAMPLE |
Population de l'étude
Adult patients undergoing a hysterectomy for benign disease
Éligibilité telle qu'elle figure dans le registre
Éligibilité en énoncés simples
Les critères de cette fiche n'ont pas encore été décomposés en énoncés distincts. Le texte du registre ci-dessus est complet et fait foi.
Conception de l'étude
| Type d'étude | Observationnelle |
|---|---|
| Phase | Non précisé dans la fiche du registre |
| Répartition | Non précisé dans la fiche du registre |
| Modèle d'intervention | Non précisé dans la fiche du registre |
| Objectif principal | Non précisé dans la fiche du registre |
| Insu | Non précisé dans la fiche du registre |
| Recrutement | 112 participants recherchés |
Promoteur et collaborateurs
- Distalmotion SA Promoteur
Interventions
- Dispositif benign hysterectomy
Robotic-assisted and laparoscopic hysterectomy for benign disease with the DEXTER robotic surgery system.
Critères de jugement
Critère de jugement principal
Primary safety outcome
Occurrence of Clavien-Dindo grades III-V adverse events
Délai up to 42 days after surgery
Critère de jugement principal
Primary efficacy outcome
Successful completion of the DEXTER-assisted procedure, i.e. free of any conversion to an open or fully laparoscopic surgical approach
Délai Intraoperative
Dates
| Date de début | 20 août 2026 (réelle) |
|---|---|
| Achèvement principal | 1 décembre 2028 (estimée) |
| Achèvement | 1 décembre 2028 (estimée) |
| Première publication | 5 août 2026 (réelle) |
| Dernière mise à jour | 17 novembre 2026 |
| Résultats publiés | Non précisé dans la fiche du registre |
| Statut vérifié pour la dernière fois | novembre 2026 |
Réelle signifie que l'événement a eu lieu. Estimée signifie que le promoteur s'y attend. Les deux ont un sens différent.
Lieux
1 site est en recrutement
United States
| Établissement | Ville | État ou région | Statut |
|---|---|---|---|
| Memorial Hermann-Texas Medical Center - UT Health Houston | Houston | Texas | Pas encore en recrutement |
| Cypress surgery center | Wichita | Kansas | En recrutement |
Documents de l'étude
Aucun document n'est lié dans cette fiche du registre.
Évolution au fil du temps
- 17 novembre 2026
Statut modifié
Status changed from Not yet recruiting to Recruiting
NOT_YET_RECRUITINGRECRUITING
- 17 novembre 2026
Recrutement ouvert
Recruitment opened
NOT_YET_RECRUITINGRECRUITING